Icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K–AKT–eNOS–NO–cGMP–PKG
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81270963)
This publication has 51 references indexed in Scilit:
- Icariin Protects Against Glucocorticoid-Induced Osteoporosis In Vitro and Prevents Glucocorticoid-Induced Osteocyte Apoptosis In VivoCell Biochemistry and Biophysics, 2013
- Aging and bone loss: new insights for the clinicianTherapeutic Advances in Musculoskeletal Disease, 2011
- Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitroJournal of Cellular Biochemistry, 2010
- Synaptic Plasticity and NO-cGMP-PKG Signaling Regulate Pre- and Postsynaptic Alterations at Rat Lateral Amygdala Synapses Following Fear ConditioningPLOS ONE, 2010
- Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor‐dependent osteoblastic functions in UMR 106 cellsBritish Journal of Pharmacology, 2010
- Akt promotes BMP2-mediated osteoblast differentiation and bone developmentJournal of Cell Science, 2009
- Nitric oxide production during the osteogenic differentiation of human periodontal ligament mesenchymal stem cellsActa Histochemica, 2009
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002